Localized Stage Plasmablastic Lymphoma with Ulcerative Colitis in Long-term Remission after Chemoradiotherapy
Authors:
Open Access
- 15 March 2026
- journal article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 65 (6) , 873-877
Abstract
Plasmablastic lymphoma (PBL) is a rare and aggressive B-cell lymphoma with a poor prognosis and is typically linked to HIV-related immunodeficiency. PBL associated with ulcerative colitis (UC) is an extremely rare condition. We report the case of a 63-year-old HIV-negative woman with UC who developed colonic PBL after long-term mesalazine and budesonide treatment. She achieved complete remission following chemotherapy and abdominal radiotherapy, with no recurrence for more than three years. To our knowledge, this is the fourth reported case of UC-associated PBL and demonstrates the longest survival. Chemoradiotherapy may be an effective treatment for localized PBL.Keywords
This publication has 26 references indexed in Scilit:
- Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapyClinical Journal of Gastroenterology, 2023
- Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective studyAmerican Journal of Hematology, 2023
- Unique presentation of a plasmablastic lymphoma superficially involving the entire large bowelPathology - Research and Practice, 2015
- Autologous Hematopoietic Stem Cell Transplantation for Plasmablastic Lymphoma: The European Society for Blood and Marrow Transplantation ExperienceTransplantation and Cellular Therapy, 2015
- Hematopoietic Cell Transplantation for Plasmablastic Lymphoma: A ReviewTransplantation and Cellular Therapy, 2014
- Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti‐TNF alpha antibodiesPharmacoepidemiology and Drug Safety, 2014
- Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- HIV-Negative Plasmablastic Lymphoma: Not in the MouthClinical Lymphoma Myeloma and Leukemia, 2011
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort studyThe Lancet, 2009
- HIV‐associated plasmablastic lymphoma: Lessons learned from 112 published casesAmerican Journal of Hematology, 2008